tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Tharimmune Completes Private Placement Agreement

Story Highlights
Tharimmune Completes Private Placement Agreement

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

An update from Tharimmune ( (THAR) ) is now available.

On July 31, 2025, Tharimmune, Inc. completed a private placement agreement with accredited investors, resulting in the issuance and sale of common stock and warrants. The transaction, which closed after meeting customary conditions, is expected to generate gross proceeds of $1,225,003. The company plans to use the net proceeds for clinical development and working capital, with President Street Global serving as the exclusive placement agent.

The most recent analyst rating on (THAR) stock is a Buy with a $17.00 price target. To see the full list of analyst forecasts on Tharimmune stock, see the THAR Stock Forecast page.

More about Tharimmune

Average Trading Volume: 52,135

Technical Sentiment Signal: Sell

Current Market Cap: $5.66M

For detailed information about THAR stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1